Blog
RSS FeedPosted by Michael Wonder on 21 Oct 2019
Annual performance statistics report: July 2018 to June 2019
21 October 2019 - At 30 June 2019 there were 88,788 therapeutic goods on the ARTG, including 31,987 new products added ...
Posted by Michael Wonder on 12 Oct 2017
Health care: the measure of a robust system
13 October 2017 - For all its faults, for all the times that things don’t go as planned, Australia’s health system ...
Posted by Michael Wonder on 12 Sep 2017
Annual performance statistics report: July 2016 to June 2017
12 September 2017 - Since the 2015-16 report, the number of submissions received across some Category 1 application types varied significantly. ...
Posted by Michael Wonder on 14 Nov 2016
TGA key performance indicators: July 2015 to June 2016
14 November 2016 - The TGA has published a self-assessed rating of its overall performance for the year ending 30 ...
Posted by Michael Wonder on 04 Jan 2016
2015: another strong year for patients in need of new drug therapies
4 January 2016 - In 2015, FDA’s CDER approved 45 novel new therapies – significantly more than the average of 28 ...
Posted by Michael Wonder on 23 Sep 2015
No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog
17 September 2015 - There is no way of knowing whether the Cancer Drugs Fund, which has cost the NHS £1bn ...
Posted by Michael Wonder on 17 Sep 2015
CDF has improved drugs access but is not sustainable, NAO finds
17 September 2015 - England’s Cancer Drug Fund has improved patient access to novel cancer drugs not routinely available on the ...
Posted by Michael Wonder on 10 Sep 2015
Smart buys and PBS shift pay off for Sigma
11 September 2015 - Sigma Pharmaceuticals boss Mark Hooper says the business is in a “good position”, flagging earnings growth on ...
Posted by Michael Wonder on 03 Sep 2015
TGA key performance indicators: January to June 2015
3 September 2015 - The performance of the TGA is measured through eight key performance indicators (KPIs): ...